Katherine Abrahams

Katherine Abrahams serves as a Research Fellow at the Biosciences Institute of Microbiology and Infection, where she conducts significant research on tuberculosis and Mycobacterium tuberculosis. Her work focuses on identifying drug targets and developing novel antitubercular agents through biochemical and pharmacological approaches.

Her research interests span multiple critical areas in tuberculosis research including Mycobacterium tuberculosis biology, antitubercular agents development, enzyme biochemistry related to drug targets, and minimum inhibitory concentration studies. Her work particularly emphasizes the bacterial cell wall and mycobacterial cell envelope synthesis pathways, which are crucial for developing new tuberculosis treatments.

Analysis of her recent publications reveals a strong focus on molecular targets for tuberculosis treatment, particularly examining the DprE2 enzyme system and its interaction with nitroimidazole compounds like pretomanid and delamanid. Her research also explores novel activation mechanisms for anti-tubercular compounds, such as the role of monoglyceride lipase Rv0183 in activating rhein derivatives.

Her collaborative work, particularly with Professor G.S. Besra, demonstrates a sustained research program with consistent output from 2012 through 2024, totaling 18 research publications. Her work has gained recognition with mentions in Wikipedia pages, news outlets, and significant attention on academic platforms like Mendeley.